Obinepitide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameObinepitide
Drug Alias Name奥比匹肽obinepitidaobinepitidum奥尼匹肽[Gln34]-Pancreatic polypeptide +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeuropeptide Y receptor type 4 agonistsNeuropeptide Y receptor type 2 agonists
TargetsNeuropeptide Y receptor type 2Neuropeptide Y receptor type 4
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator Companies7tm Pharma As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies7tm Pharma As
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksDrugBank